156
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Clinical Features and CT Imaging Analysis of Hepatic Sinuscase-Syndrome and Budd–Chiari Syndrome

, , ORCID Icon, , , ORCID Icon & show all
Pages 2389-2396 | Published online: 02 Mar 2022

References

  • Helmy A. Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome. Aliment Pharmacol Ther. 2006;23(1):11–25. doi:10.1111/j.1365-2036.2006.02742.x
  • Lin G, Wang JY, Li N, et al. Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum. J Hepatol. 2011;54(4):666–673. doi:10.1016/j.jhep.2010.07.031
  • Soni N, Israrahmed A, Singh P, et al. Caput medusa: a sign of portal hypertension on case of chronic Budd-Chiari syndrome. BMJ Case Rep. 2021;14(4):e242076. doi:10.1136/bcr-2021-242076
  • Balducci G, Sterpetti AV, Ventura M. A short history of portal hypertension and of its management. J Gastroenterol Hepatol. 2016;31(3):541–545. doi:10.1111/jgh.13200
  • Shi TT, He J, Zhuge YZ, et al. CT feature of hepatic veno-occlusive disease caused by Gynura segetum. J Pract Radiol. 2016;32:875–878.
  • Kan XF, Ye J, Rong XX, et al. Diagnostic performance of contrast-enhanced CT in pyrrolizidine alkaloids-induced hepatic sinusoidal obstructive syndrome. Sci Rep. 2016;6(1):37998. doi:10.1038/srep37998
  • Cayet S, Pasco J, Dujardin F, et al. Diagnostic performance of contrast-enhanced CT-scan in sinusoidal obstruction syndrome induced by chemotherapy of colorectal liver metastases: radio-pathological correlation. Eur J Radiol. 2017;94:180–190. doi:10.1016/j.ejrad.2017.06.025
  • Yang XQ, Ye J, Li X, et al. Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes. World J Gastroenterol. 2019;25(28):3753–3763. doi:10.3748/wjg.v25.i28.3753
  • Ulas DB, Soley S, Yusuf B. Hepatic venous outflow obstruction: three similar syndromes. World J Gastrenterol. 2007;13(13):1912–1927. doi:10.3748/wjg.v13.i13.1912
  • Wang JY, Gao H. Tusanqi and hepatic sinusoidal obstruction syndrome. J Dig Dis. 2014;15(3):105–107. doi:10.1111/1751-2980.12112
  • Deleve LD, Shulman HM, McDonald GB. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome. Semin Liver Dis. 2002;22(1):27–42. doi:10.1055/s-2002-23204
  • Kan XF, Ye J, Rong XX, et al. Diagnostic performance of contrast-enhanced CT in pyrrolizidine Alkaloids-induced hepatic sinusoidal obstructive syndrome. Sci Rep. 2016;6(11):1–8.
  • Zhou H, Wang YX, Lou HY, et al. Hepatic sinusoidal obstruction syndrome caused by herbal medicine: CT and MRI features. Korean J Radiol. 2014;15(2):218–225. doi:10.3348/kjr.2014.15.2.218
  • Sun ZY, Kang JM, Zhang YC. Hepatic veno-occlusive disease related to Gynura segetum: a case report. Medicine (Baltimore). 2018;97(17):e0552. doi:10.1097/MD.0000000000010552
  • Erturk SM, Mortele KJ, Binkert CA, et al. CT features of hepatic veno occlusive disease and hepatic graft-versus-host disease in patients after hematopoietic stem cell transplantation. AJR. 2006;186(6):1497–1501. doi:10.2214/AJR.05.0539